Drugs / PRX-P4-003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04638803 | Feb → Oct 2021 | — | Praxis Bioresearch, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRX-P4-003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04638803 ↗ |
| Route | Oral | “following oral administration of a microdose of PRX-P4-003 (100 µg) in a fed state” NCT04638803 ↗ |